Dimensional Fund Advisors LP 13D and 13G filings for Lifecore Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 09:59 am Sale |
2024-02-14 | 13G | Lifecore Biomedical, Inc. LFCR |
Dimensional Fund Advisors LP | 1,940 0.000% |
-1,755,604 (-99.89%) |
Filing |
| 2023-02-10 2:42 pm Sale |
2023-02-14 | 13G | Lifecore Biomedical, Inc. LFCR |
Dimensional Fund Advisors LP | 1,757,544 5.900% |
-216,064 (-10.95%) |
Filing |
| 2022-02-08 3:52 pm Sale |
2022-02-14 | 13G | Lifecore Biomedical, Inc. LFCR |
Dimensional Fund Advisors LP | 1,973,608 6.700% |
-245,753 (-11.07%) |
Filing |
| 2021-02-12 5:13 pm Sale |
2021-02-16 | 13G | Lifecore Biomedical, Inc. LFCR |
Dimensional Fund Advisors LP | 2,219,361 7.600% |
-212,172 (-8.73%) |
Filing |